rs10515198

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000859.3(HMGCR):​c.450+77G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0953 in 874,494 control chromosomes in the GnomAD database, including 4,554 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.082 ( 592 hom., cov: 32)
Exomes 𝑓: 0.098 ( 3962 hom. )

Consequence

HMGCR
NM_000859.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.771

Publications

16 publications found
Variant links:
Genes affected
HMGCR (HGNC:5006): (3-hydroxy-3-methylglutaryl-CoA reductase) HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
HMGCR Gene-Disease associations (from GenCC):
  • muscular dystrophy, limb-girdle, autosomal recessive 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HMGCRNM_000859.3 linkc.450+77G>A intron_variant Intron 5 of 19 ENST00000287936.9 NP_000850.1 P04035-1A0A024RAP2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HMGCRENST00000287936.9 linkc.450+77G>A intron_variant Intron 5 of 19 1 NM_000859.3 ENSP00000287936.4 P04035-1

Frequencies

GnomAD3 genomes
AF:
0.0818
AC:
12439
AN:
152032
Hom.:
591
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0327
Gnomad AMI
AF:
0.0549
Gnomad AMR
AF:
0.115
Gnomad ASJ
AF:
0.165
Gnomad EAS
AF:
0.0271
Gnomad SAS
AF:
0.122
Gnomad FIN
AF:
0.111
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0976
Gnomad OTH
AF:
0.0705
GnomAD4 exome
AF:
0.0981
AC:
70876
AN:
722344
Hom.:
3962
AF XY:
0.0998
AC XY:
38436
AN XY:
384964
show subpopulations
African (AFR)
AF:
0.0315
AC:
566
AN:
17946
American (AMR)
AF:
0.141
AC:
5084
AN:
36022
Ashkenazi Jewish (ASJ)
AF:
0.169
AC:
3404
AN:
20122
East Asian (EAS)
AF:
0.0184
AC:
652
AN:
35518
South Asian (SAS)
AF:
0.124
AC:
8177
AN:
65830
European-Finnish (FIN)
AF:
0.110
AC:
5371
AN:
48990
Middle Eastern (MID)
AF:
0.0722
AC:
299
AN:
4144
European-Non Finnish (NFE)
AF:
0.0959
AC:
43935
AN:
458222
Other (OTH)
AF:
0.0953
AC:
3388
AN:
35550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
2990
5981
8971
11962
14952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0817
AC:
12435
AN:
152150
Hom.:
592
Cov.:
32
AF XY:
0.0830
AC XY:
6173
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0326
AC:
1355
AN:
41516
American (AMR)
AF:
0.116
AC:
1768
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.165
AC:
573
AN:
3472
East Asian (EAS)
AF:
0.0266
AC:
138
AN:
5182
South Asian (SAS)
AF:
0.121
AC:
582
AN:
4822
European-Finnish (FIN)
AF:
0.111
AC:
1172
AN:
10572
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0976
AC:
6635
AN:
67984
Other (OTH)
AF:
0.0698
AC:
147
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
565
1130
1694
2259
2824
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0939
Hom.:
964
Bravo
AF:
0.0766
Asia WGS
AF:
0.0760
AC:
263
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.0
DANN
Benign
0.71
PhyloP100
-0.77
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10515198; hg19: chr5-74641560; API